featured
SARS-CoV-2 Delta Variant Neutralization After Heterologous ChAdOx1-S/BNT162b2 Vaccination
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
SARS-CoV-2 Delta Variant Neutralisation After Heterologous ChAdOx1-S/BNT162b2 Vaccination
Lancet 2021 Aug 17;[EPub Ahead of Print], GM Behrens, A Cossmann, MV Stankov, I Nehlmeier, A Kempf, M Hoffmann, S PöhlmannFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.